Beijing Dongfang Biotech Co., Ltd.
Clinical trials sponsored by Beijing Dongfang Biotech Co., Ltd., explained in plain language.
-
New diabetes drug JY09 takes on dulaglutide in major trial
Disease control OngoingThis study tests whether a new drug called JY09 works better than an existing drug, dulaglutide, for people with type 2 diabetes that is not well controlled by metformin alone. About 600 adults will receive either JY09 or dulaglutide added to their metformin. The main goal is to …
Phase: PHASE3 • Sponsor: Beijing Dongfang Biotech Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New diabetes drug JY09 aims to lower blood sugar in patients not helped by diet alone
Disease control OngoingThis study tests a new medicine called JY09 in 270 adults with type 2 diabetes whose blood sugar is not well controlled by diet and exercise alone. Participants receive either JY09 or a placebo for up to 54 weeks. The main goal is to see if JY09 safely lowers blood sugar levels (…
Phase: PHASE3 • Sponsor: Beijing Dongfang Biotech Co., Ltd. • Aim: Disease control
Last updated May 19, 2026 11:46 UTC